Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:39:06 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



News for C:MSCL from 2023-05-08 to 2024-05-07 - 35 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-03-27 16:42C:MSCLSatellos Bioscience Inc0.48SEDAR MD & ASEDAR MD & A
2024-03-27 15:50C:MSCLSatellos Bioscience Inc0.46SEDAR MD & ASEDAR MD & A
2024-03-27 15:44C:MSCLSatellos Bioscience Inc0.46SEDAR Annual Information FormSEDAR Annual Information Form
2024-03-27 15:44C:MSCLSatellos Bioscience Inc0.46SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-27 11:14C:MSCLSatellos Bioscience Inc0.48News ReleaseSatellos Bioscience's Dec. 31 cash at $39.6-million
2024-02-14 11:10C:MSCLSatellos Bioscience Inc0.55News ReleaseSatellos Bioscience to begin trading on TSX Feb. 15
2024-02-13 19:56C:MSCLSatellos Bioscience Inc0.55Shares Delisted from TSX-VSatellos Bioscience to be delisted from TSX-V
2024-02-13 15:01C:MSCLSatellos Bioscience Inc0.55New ListingSatellos Bioscience to trade on TSX Feb. 15
2024-02-13 11:19C:MSCLSatellos Bioscience Inc0.53News ReleaseSatellos Bioscience releases SAT-3247 preliminary data
2024-01-26 11:38C:MSCLSatellos Bioscience IncSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-01-23 10:08C:MSCLSatellos Bioscience Inc0.55News ReleaseSatellos names Dubow chief medical adviser
2024-01-16 11:45C:MSCLSatellos Bioscience Inc0.45News ReleaseSatellos Bioscience receives cond. OK for TSX listing
2023-11-22 14:30C:MSCLSatellos Bioscience Inc0.50SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-22 14:28C:MSCLSatellos Bioscience Inc0.50SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-22 10:41C:MSCLSatellos Bioscience Inc0.475News ReleaseSatellos Bioscience's Sept. 30 cash at $44.3-million
2023-11-14 13:38C:MSCLSatellos Bioscience Inc0.35News ReleaseSatellos sets AAK1 as drug target to treat Duchenne
2023-09-07 17:15C:MSCLSatellos Bioscience Inc0.495News ReleaseSatellos hires ICP for market making services
2023-09-05 14:28C:MSCLSatellos Bioscience Inc0.415News ReleaseSatellos Bioscience appoints Williams as CFO
2023-08-29 12:50C:MSCLSatellos Bioscience Inc0.45News ReleaseSatellos Bioscience spends $873,012 on R&D in Q2
2023-08-28 07:02C:MSCLSatellos Bioscience Inc0.45SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-28 07:01C:MSCLSatellos Bioscience Inc0.45SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-14 19:17C:MSCLSatellos Bioscience Inc0.42Prospectus ApprovedSatellos Bioscience prospectus offering
2023-08-02 09:13C:MSCLSatellos Bioscience Inc0.425News ReleaseSatellos receives orphan drug designation for SAT-3153
2023-06-30 12:14C:MSCLSatellos Bioscience Inc0.50News ReleaseSatellos shareholders elect eight directors at AGM
2023-06-07 11:47C:MSCLSatellos Bioscience Inc0.56News ReleaseSatellos appoints Jacobs as chief medical officer
2023-06-01 12:40C:MSCLSatellos Bioscience Inc0.60News ReleaseSatellos grants options to buy 5.73 million shares
2023-05-30 19:26C:MSCLSatellos Bioscience Inc0.55SEDAR MD & ASEDAR MD & A
2023-05-30 19:20C:MSCLSatellos Bioscience Inc0.55SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-30 19:00C:MSCLSatellos Bioscience Inc0.55News ReleaseSatellos's March 31 cash at $2.98-million
2023-05-29 16:45C:MSCLSatellos Bioscience Inc0.56SEDAR Early Warning ReportSEDAR Early Warning Report
2023-05-17 17:45C:MSCLSatellos Bioscience Inc0.53News ReleaseSatellos Bioscience shareholder Bloom adds to holdings
2023-05-17 17:38C:MSCLSatellos Bioscience Inc0.53SEDAR Early Warning ReportSEDAR Early Warning Report
2023-05-17 13:32C:MSCLSatellos Bioscience Inc0.53News ReleaseSatellos Bioscience closes $55-million offering
2023-05-10 21:24C:MSCLSatellos Bioscience Inc0.61News ReleaseSatellos files final prospectus for shares
2023-05-10 13:11C:MSCLSatellos Bioscience Inc0.61SEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus